Robeauté
France - ParisBiotechnology
Focus: Robeauté is a Paris-based neurosurgical robotics biotechnology company founded in 2022, focused on precision surgical solutions in oncology and neurology. With 51-200 employees, the company operates at the intersection of medical devices and biotech innovation.
Profile data last refreshed 13h ago · AI intelligence enriched 3w ago
Employees
51-200
Total Funding
$28M
Open Jobs
9-3 this month
Stable — net -3 jobs in 30d
3 added, 6 removed. Backfill posture.
Should You Work at Robeauté?
AI assessmentRobeauté is a high-risk, high-potential early-stage deeptech play best suited for engineers and product professionals comfortable with startup uncertainty and seeking to build robotics IP from the ground up.
Why Work Here
- Ground-floor opportunity at an early-stage (2022 founding) deep-tech company with focused specialization in high-value neurosurgical robotics
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Robeauté
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.